In March 1 Journal of Clinical Investigation Thomas Zollner and colleagues from JW Goethe University of Frankfurt, Germany, show that proteasome inhibition reduces superantigen-mediated T cell ...
Reporting in Nature, Lin and colleagues show that selective inhibition of the mycobacterial proteasome with certain oxathiazol-2-one compounds might be useful in targeting this non-replicating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback